AS703569 and Gemcitabine Combination in Advanced Malignancies

Clinical trial NCT01097512 · COMPLETED

Trial details

NCT number: NCT01097512
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2007-06-01
Primary completion: 2010-07-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.